![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 19153 |
FusionGeneSummary for KNG1_ALB |
![]() |
Fusion gene information | Fusion gene name: KNG1_ALB | Fusion gene ID: 19153 | Hgene | Tgene | Gene symbol | KNG1 | ALB | Gene ID | 3827 | 213 |
Gene name | kininogen 1 | albumin | |
Synonyms | BDK|BK|HMWK|KNG | HSA|PRO0883|PRO0903|PRO1341 | |
Cytomap | 3q27.3 | 4q13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | kininogen-1alpha-2-thiol proteinase inhibitorbradykininfitzgerald factorhigh molecular weight kininogenwilliams-Fitzgerald-Flaujeac factor | serum albumin | |
Modification date | 20180523 | 20180522 | |
UniProtAcc | P01042 | P02768 | |
Ensembl transtripts involved in fusion gene | ENST00000287611, ENST00000265023, ENST00000447445, | ENST00000295897, ENST00000415165, ENST00000503124, ENST00000509063, ENST00000401494, ENST00000505649, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 27 X 26 X 2=1404 |
# samples | 1 | 33 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(33/1404*10)=-2.08900500605874 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: KNG1 [Title/Abstract] AND ALB [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | KNG1 | GO:0007162 | negative regulation of cell adhesion | 11970955 |
Hgene | KNG1 | GO:0007204 | positive regulation of cytosolic calcium ion concentration | 16014619 |
Hgene | KNG1 | GO:0030195 | negative regulation of blood coagulation | 11970955 |
Hgene | KNG1 | GO:0045861 | negative regulation of proteolysis | 3488317 |
Tgene | ALB | GO:0009267 | cellular response to starvation | 16245148 |
Tgene | ALB | GO:0019836 | hemolysis by symbiont of host erythrocytes | 16394536 |
Tgene | ALB | GO:0043066 | negative regulation of apoptotic process | 16153637 |
Tgene | ALB | GO:0051659 | maintenance of mitochondrion location | 16153637 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | DA640348 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000287611 | ENST00000295897 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-5UTR | ENST00000287611 | ENST00000415165 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000287611 | ENST00000503124 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000287611 | ENST00000509063 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000287611 | ENST00000401494 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000287611 | ENST00000505649 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-5UTR | ENST00000265023 | ENST00000295897 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-5UTR | ENST00000265023 | ENST00000415165 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000265023 | ENST00000503124 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000265023 | ENST00000509063 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000265023 | ENST00000401494 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000265023 | ENST00000505649 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-5UTR | ENST00000447445 | ENST00000295897 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-5UTR | ENST00000447445 | ENST00000415165 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000447445 | ENST00000503124 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000447445 | ENST00000509063 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000447445 | ENST00000401494 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
5CDS-intron | ENST00000447445 | ENST00000505649 | KNG1 | chr3 | 186435462 | + | ALB | chr4 | 74270004 | + |
Top |
FusionProtFeatures for KNG1_ALB |
![]() |
Hgene | Tgene |
KNG1 | ALB |
(1) Kininogens are inhibitors of thiol proteases; (2)HMW-kininogen plays an important role in blood coagulation byhelping to position optimally prekallikrein and factor XI next tofactor XII; (3) HMW-kininogen inhibits the thrombin- and plasmin-induced aggregation of thrombocytes; (4) the active peptidebradykinin that is released from HMW-kininogen shows a variety ofphysiological effects: (4A) influence in smooth musclecontraction, (4B) induction of hypotension, (4C) natriuresis anddiuresis, (4D) decrease in blood glucose level, (4E) it is amediator of inflammation and causes (4E1) increase in vascularpermeability, (4E2) stimulation of nociceptors (4E3) release ofother mediators of inflammation (e.g. prostaglandins), (4F) it hasa cardioprotective effect (directly via bradykinin action,indirectly via endothelium-derived relaxing factor action); (5)LMW-kininogen inhibits the aggregation of thrombocytes; (6) LMW-kininogen is in contrast to HMW-kininogen not involved in bloodclotting. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for KNG1_ALB |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for KNG1_ALB |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KNG1_ALB |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | KNG1 | P01042 | DB01593 | Zinc | Kininogen-1 | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB00493 | Cefotaxime | Serum albumin | small molecule | approved |
Tgene | ALB | P02768 | DB01045 | Rifampicin | Serum albumin | small molecule | approved |
Tgene | ALB | P02768 | DB03255 | Phenol | Serum albumin | small molecule | approved|experimental |
Tgene | ALB | P02768 | DB00276 | Amsacrine | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB00545 | Pyridostigmine | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB06713 | Norelgestromin | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB11638 | Artenimol | Serum albumin | small molecule | approved|investigational |
Tgene | ALB | P02768 | DB00199 | Erythromycin | Serum albumin | small molecule | approved|investigational|vet_approved |
Top |
RelatedDiseases for KNG1_ALB |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | KNG1 | C0020429 | Hyperalgesia | 17 | CTD_human |
Hgene | KNG1 | C0020649 | Hypotension | 9 | CTD_human |
Hgene | KNG1 | C0030193 | Pain | 6 | CTD_human |
Hgene | KNG1 | C0011609 | Drug Eruptions | 2 | CTD_human |
Hgene | KNG1 | C0027055 | Myocardial Reperfusion Injury | 2 | CTD_human |
Hgene | KNG1 | C2609414 | Acute kidney injury | 2 | CTD_human |
Hgene | KNG1 | C0002792 | anaphylaxis | 1 | CTD_human |
Hgene | KNG1 | C0003811 | Cardiac Arrhythmia | 1 | CTD_human |
Hgene | KNG1 | C0010200 | Coughing | 1 | CTD_human |
Hgene | KNG1 | C0013604 | Edema | 1 | CTD_human |
Hgene | KNG1 | C0015379 | Extravasation of Diagnostic and Therapeutic Materials | 1 | CTD_human |
Hgene | KNG1 | C0019243 | Angioedemas, Hereditary | 1 | CTD_human |
Hgene | KNG1 | C0020452 | Hyperemia | 1 | CTD_human |
Hgene | KNG1 | C0020453 | Hyperesthesia | 1 | CTD_human |
Hgene | KNG1 | C0020517 | Hypersensitivity | 1 | CTD_human |
Hgene | KNG1 | C0020538 | Hypertensive disease | 1 | CTD_human |
Hgene | KNG1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | KNG1 | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
Hgene | KNG1 | C0039231 | Tachycardia | 1 | CTD_human |
Hgene | KNG1 | C0428977 | Bradycardia | 1 | CTD_human |
Hgene | KNG1 | C2931758 | Acquired angioedema | 1 | CTD_human |
Tgene | ALB | C0033687 | Proteinuria | 9 | CTD_human |
Tgene | ALB | C0017658 | Glomerulonephritis | 8 | CTD_human |
Tgene | ALB | C0022658 | Kidney Diseases | 8 | CTD_human |
Tgene | ALB | C0017665 | Membranous glomerulonephritis | 6 | CTD_human |
Tgene | ALB | C0027697 | Nephritis | 6 | CTD_human |
Tgene | ALB | C0027707 | Nephritis, Interstitial | 4 | CTD_human |
Tgene | ALB | C0038454 | Cerebrovascular accident | 4 | CTD_human |
Tgene | ALB | C0342185 | Hyperthyroxinemia, Familial Dysalbuminemic | 4 | CTD_human;UNIPROT |
Tgene | ALB | C0023893 | Liver Cirrhosis, Experimental | 3 | CTD_human |
Tgene | ALB | C0025290 | Aseptic Meningitis | 3 | CTD_human |
Tgene | ALB | C2609414 | Acute kidney injury | 3 | CTD_human |
Tgene | ALB | C0014544 | Epilepsy | 2 | CTD_human |
Tgene | ALB | C0020649 | Hypotension | 2 | CTD_human;HPO |
Tgene | ALB | C0023890 | Liver Cirrhosis | 2 | CTD_human |
Tgene | ALB | C0027726 | Nephrotic Syndrome | 2 | CTD_human |
Tgene | ALB | C0036830 | Serum Sickness | 2 | CTD_human |
Tgene | ALB | C0162557 | Liver Failure, Acute | 2 | CTD_human |
Tgene | ALB | C4277682 | Chemical and Drug Induced Liver Injury | 2 | CTD_human |
Tgene | ALB | C0002994 | Angioedema | 1 | CTD_human |
Tgene | ALB | C0003460 | Anuria | 1 | CTD_human |
Tgene | ALB | C0004509 | Azoospermia | 1 | CTD_human |
Tgene | ALB | C0006111 | Brain Diseases | 1 | CTD_human |
Tgene | ALB | C0007222 | Cardiovascular Diseases | 1 | CTD_human |
Tgene | ALB | C0007786 | Brain Ischemia | 1 | CTD_human |
Tgene | ALB | C0011581 | Depressive disorder | 1 | CTD_human |
Tgene | ALB | C0011875 | Diabetic Angiopathies | 1 | CTD_human |
Tgene | ALB | C0011881 | Diabetic Nephropathy | 1 | CTD_human |
Tgene | ALB | C0013502 | Echinococcosis | 1 | CTD_human |
Tgene | ALB | C0016059 | Fibrosis | 1 | CTD_human |
Tgene | ALB | C0017662 | Glomerulonephritis, Membranoproliferative | 1 | CTD_human |
Tgene | ALB | C0018799 | Heart Diseases | 1 | CTD_human |
Tgene | ALB | C0018801 | Heart failure | 1 | CTD_human |
Tgene | ALB | C0019061 | Hemolytic-Uremic Syndrome | 1 | CTD_human |
Tgene | ALB | C0019158 | Hepatitis | 1 | CTD_human |
Tgene | ALB | C0019693 | HIV Infections | 1 | CTD_human |
Tgene | ALB | C0019699 | HIV Seropositivity | 1 | CTD_human |
Tgene | ALB | C0020517 | Hypersensitivity | 1 | CTD_human |
Tgene | ALB | C0020522 | Delayed Hypersensitivity | 1 | CTD_human |
Tgene | ALB | C0020538 | Hypertensive disease | 1 | CTD_human |
Tgene | ALB | C0022548 | Keloid | 1 | CTD_human |
Tgene | ALB | C0022661 | Kidney Failure, Chronic | 1 | CTD_human |
Tgene | ALB | C0026848 | Myopathy | 1 | CTD_human |
Tgene | ALB | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human |
Tgene | ALB | C0027720 | Nephrosis | 1 | CTD_human |
Tgene | ALB | C0028797 | Occupational Diseases | 1 | CTD_human |
Tgene | ALB | C0030193 | Pain | 1 | CTD_human |
Tgene | ALB | C0030286 | Pancreatic Diseases | 1 | CTD_human |
Tgene | ALB | C0030305 | Pancreatitis | 1 | CTD_human |
Tgene | ALB | C0035222 | Respiratory Distress Syndrome, Adult | 1 | CTD_human |
Tgene | ALB | C0035242 | Respiratory Tract Diseases | 1 | CTD_human |
Tgene | ALB | C0035457 | Rhinitis, Allergic, Perennial | 1 | CTD_human |
Tgene | ALB | C0038325 | Stevens-Johnson Syndrome | 1 | CTD_human |
Tgene | ALB | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | ALB | C0040034 | Thrombocytopenia | 1 | CTD_human |
Tgene | ALB | C0041755 | Adverse reaction to drug | 1 | CTD_human |
Tgene | ALB | C0042109 | Urticaria | 1 | CTD_human |
Tgene | ALB | C0042164 | Uveitis | 1 | CTD_human |
Tgene | ALB | C0152013 | Adenocarcinoma of lung (disorder) | 1 | CTD_human |
Tgene | ALB | C0239981 | Hypoalbuminemia | 1 | CTD_human;HPO |
Tgene | ALB | C0993582 | Arthritis, Experimental | 1 | CTD_human |